Compounding Pharmacies Market : 2018 Prominent Players | B. Braun, Cantrell Drug company, Doughtery’s Pharmacy, Fagron, Fresenuis Kabi, Institutional Pharmacy solutions, ITC Compounding Pharmacy, Lorraine’s Pharmacy, McGuff Compounding Pharmacy Servic

Compounding Pharmacies Market size was valued over USD 8.5 billion in 2017 and is expected to witness more than 5% CAGR from 2018 to 2024.

Rising geriatric population coupled with favourable demographic trends such as improved life expectancy will render significant positive impact on compounding pharmacies market growth. Geriatric population often requires drug excipients and dosage forms that are different from commercially available products. In such scenario, compounded medications tailored to individual needs allow superior management of disease conditions. As a result, demand for compounded medications will go hand in hand with rising number of geriatric population.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/749

North America and Europe region have witnessed significant drug shortage over past few years. The reason is attributable to the product delays, inconsistent supply of raw materials and product quality issues. Shortage of drugs may have serious repercussion such as death of patients. Lack of timely availability of standard drugs will stimulate the demand for compounded medications.

High cost of sophisticated equipments required for compounding medicines coupled with dearth of availability of skilled workforce will impede the industry growth to some extent over the forecast timeframe. Ever changing regulatory scenario will further hamper the industry growth affecting the production of compounded drugs on large scale.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/749

Oral product segment dominated the market in 2017 and is forecasted to witness rapid growth over the forecast timeframe. High demand for oral liquid medications owing to associated ease of administration will boost the segment growth. Increasing preference for other oral solid dosage forms such as capsules and granules will further support the segment growth.

Adult application segment accounted for the largest market share and is poised to grow at a robust growth rate over the coming years due to increasing demand of compounded drugs for treatment of cardiovascular disease that are highly prevalent among the adults. High demand for hormonal replacement therapy from adult age group will further escalate the segment growth to some extent.

Hormone replacement segment will grow at a robust growth rate of 7% owing to the increasing demand for anti-ageing solutions. Heightened demand for bioidentical hormone replacement therapy for women, testosterone therapy for men and other high quality dermatological products that are primarily formulated in compounding pharmacies will further augment the segment growth.

U.S. dominated the global market in 2017 and will witness robust growth over the forecast period. Several government initiatives to increase adoption of compounded medicine will fuel industry growth in U.S. Growing shortage of prescription drugs and rising prices of FDA approved drugs will escalate demand for compounded medication."

China market is forecasted to grow at a robust CAGR of 8% over the coming years owing to increasing geriatric population and rapidly developing healthcare infrastructure. Growing prevalence of various age-related diseases such as arthritis, cancer, diabetes and cardiovascular diseases coupled with adverse drug reactions associated with commercially available drugs will further fuel the adoption of customized treatment driving the industry growth over the forecast period.

Some of the industry players operating in global market are Fagron, PharMEDium, B. Braun, McGuff, Institutional Pharmacy Solutions, Triangle Compounding Pharmacies, Cantrell Drug Company, Wedgewood Village Pharmacy, Fresenius Kabi, Lorraine’s Company, Dougherty’s Pharmacy, Village Compounding Pharmacy, Rx3, ITC Compounding Pharmacy and Pencol Compounding Pharmacy.

Industry players are taking efforts to develop newer and efficient systems for drug compounding. For instance, B. Braun, in 2017, launched the Apex Compounding System, specifically designed to address the immediate needs of critically ill patients while meeting the needs of pharmacists. Strategic expansion through mergers and acquisitions help the players to enhance and strengthen the product portfolio.

Compounding pharmacy market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments:

Compounding Pharmacies Market by Product
o Oral
o Topical
o Rectal
o Parenteral
o Inhaler
o Ophthalmic

Compounding Pharmacies Market by Application
o Pediatric
o Adult
o Geriatric
o Veterinary

Compounding Pharmacies Market by Therapeutic Area
o Hormone replacement
o Pain management

The above information is provided for the following regions and countries:

• North America
o U.S.
o Canada

• Europe
o Germany
o UK
o Italy
o Spain
o France
o Poland
o Ukraine
o Greece
o Sweden
o Norway
o Belgium
o Czech Republic
o Finland
o Russia

• Asia Pacific
o China
o India
o Japan
o Singapore
o Australia

• Latin America
o Argentina
o Brazil
o Mexico

• Middle East and Africa
o South Africa
o UAE
o Saudi Arabia
o Qatar
o Kuwait

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.